Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-30 Sale | 2024-08-13 4:29 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 172 | $0.22547 | $39 | 22,777 (Direct) | View |
| 2023-08-04 Sale | 2023-11-08 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 435 | $0.88846 | $386 | 22,949 (Direct) | View |
| 2023-07-06 Sale | 2023-07-19 4:07 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 106 | $1.47 | $156 | 23,384 (Direct) | View |
| 2023-06-30 Purchase | 2023-07-06 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 17,702 | $1.52 | $26,907 | 23,490 (Direct) | View |
| 2023-03-31 Sale | 2023-07-06 4:16 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 303 | $2.4625 | $746 | 23,490 (Direct) | View |
| 2023-01-24 Sale | 2023-03-07 4:11 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 418 | $8.8703 | $3,708 | 6,091 (Direct) | View |
| 2022-11-28 Sale | 2022-12-20 4:35 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 372,113 | $0.16914 | $62,938 | 325,404 (Direct) | View |
| 2022-11-04 Sale | 2022-11-10 4:10 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 8,393 | $0.27247 | $2,287 | 332,761 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 5:29 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS CFO | 8,293 | $0.28085 | $2,329 | 338,670 (Direct) | View |
| 2022-09-06 Sale | 2022-09-12 4:05 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,828 | $0.39 | $1,883 | 346,963 (Direct) | View |
| 2022-08-05 Sale | 2022-08-11 4:30 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,728 | $0.47 | $2,222 | 351,791 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 4:08 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,630 | $0.55 | $2,547 | 356,519 (Direct) | View |
| 2022-06-01 Sale | 2022-06-06 4:49 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,478 | $0.96 | $4,299 | 361,149 (Direct) | View |
| 2022-05-31 Purchase | 2022-06-01 2:18 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 20,000 | $0.92112 | $18,422 | 365,627 (Direct) | View |
| 2022-05-05 Sale | 2022-05-12 4:05 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,529 | $0.77 | $3,487 | 345,627 (Direct) | View |
| 2022-04-01 Sale | 2022-04-08 4:27 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 5,038 | $1.13 | $5,693 | 350,156 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 4:15 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS CFO | 3,658 | $1.06 | $3,877 | 355,194 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:22 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,684 | $1.22 | $4,494 | 358,852 (Direct) | View |
| 2022-01-04 Sale | 2022-01-28 4:46 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,171 | $1.78 | $5,644 | 362,536 (Direct) | View |
| 2021-12-02 Sale | 2021-12-09 4:17 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,304 | $1.827 | $7,863 | 365,707 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-18 4:32 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 20,000 | $2.02 | $40,400 | 370,011 (Direct) | View |
| 2021-11-02 Sale | 2021-11-16 4:14 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,320 | $2.69 | $11,621 | 350,011 (Direct) | View |
| 2021-10-01 Sale | 2021-10-12 7:40 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 3,660 | $2.76 | $10,102 | 354,331 (Direct) | View |
| 2021-09-10 Sale | 2021-09-17 6:51 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 48,366 | $2.89 | $139,778 | 357,991 (Direct) | View |
| 2021-08-30 Purchase | 2021-08-31 4:31 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 15,000 | $3.429 | $51,435 | 32,613 (Direct) | View |
| 2021-08-20 Purchase | 2021-08-24 08:59 am | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 15,000 | $3.219 | $48,285 | 17,613 (Direct) | View |
| 2020-09-16 Purchase | 2020-09-17 6:08 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 530 | $3 | $1,590 | 4,635 (Direct) | View |
| 2020-08-19 Purchase | 2020-08-20 4:18 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,105 | $3 | $12,315 | 4,105 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-17 Option Award | 2022-12-20 4:35 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 364,756 | $0 | 325,404 (Direct) | View |
| 2021-07-22 Option Award | 2021-09-17 6:51 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 372,744 | $0 | 357,991 (Direct) | View |
Ownership | 2021-06-24 5:29 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 0 | $0 | 2,613 (Direct) | View |
| 2021-06-15 Disposition | 2021-06-17 4:06 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,635 | $3.05 | 0 (Direct) | View |